SCOPUS 정보 검색 플랫폼

Lancet

Volumn 355, Issue 9201, 2000, Pages 330-331

Difficulties with oral platelet glycoprotein IIb/IIIa receptor antagonists

(2) Heeschen, Christopher a Hamm, Christian W b

a STANFORD UNIVERSITY SCHOOL OF MEDICINE (United States)

b KERCKHOFF HEART CENTER (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; ORBOFIBAN; SIBRAFIBAN; XEMILOFIBAN;

ACUTE HEART INFARCTION; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; DRUG RESEARCH; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0034728104 PISSN: 01406736 EISSN: None Source Type: Journal
DOI: 10.1016/S0140-6736(99)00464-X Document Type: Note

Times cited : (40)

References (12)

1
- 0028120906
- Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
- (1994) BMJ , vol.308 , pp. 81-106

2
- 0030918995
- Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
- (1997) Lancet , vol.349 , pp. 1429-1435

3
- 2642599026
- Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
- (1998) N Engl J Med , vol.338 , pp. 1488-1497

4
- 0032560628
- International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina
- (1998) Circulation , vol.97 , pp. 2386-2395

5
- 0008926519
- Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
- (1998) N Engl J Med , vol.339 , pp. 436-443

6
- 85031605464
- 48th Annual Scientific Session of the American College of Cardiology, New Orleans, Mar 7-10
- (1999) Efficacy and safety of Xemilofiban, an oral IIbIIIa platelet inhibitor, in patients undergoing PTCA or stent placement
- O'Neill, W.W.¹

7
- 85031614337
- 48th Annual Scientific Session of the American College of Cardiology, New Orleans, Mar 7-10
- (1999) Orbofiban in patients with unstable coronary syndromes
- Cannon, C.P.¹

8
- 0032477680
- Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: Results of the TIMI 12 trial
- (1998) Circulation , vol.97 , pp. 340-349
- Cannon, C.P.¹ McCabe, C.H.² Borzak, S.³

9
- 0033537494
- Rapid platelet-function assay: An automated and quantitative cartridge-based method
- (1999) Circulation , vol.99 , pp. 620-625
- Smith, J.W.¹ Steinhubl, S.R.² Lincoff, A.M.³

10
- 0033609314
- Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators
- (1999) N Engl J Med , vol.340 , pp. 1623-1629
- Hamm, C.W.¹ Heeschen, C.² Goldmann, B.U.³

11
- 0033589739
- Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM study investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management
- (1999) Lancet , vol.354 , pp. 1757-1762
- Heeschen, C.¹ Hamm, C.W.² Goldmann, B.³ Deu, A.⁴ Langenbrink, L.⁵ White, H.D.⁶

12
- 85031598656
- Troponin-I identifies patients with unstable coronary artery disease who benefit from long-term oral glycoprotein IIb/IIIa inhibition
- 72nd Annual Scientific Session of the American Heart Association, Atlanta, Nov 8-11
- (1999)
- Akkerhuis, M.¹ Van den Zwaan, C.² Wilcox, R.G.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.